The role of Gliadel wafers in the treatment of high-grade gliomas

Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results

(2013) Andrea Salmaggi et al.   JOURNAL OF NEUROSURGERY

Gene Expression Profile of Glioblastoma Peritumoral Tissue: An Ex Vivo Study

(2013) Annunziato Mangiola et al.   PLoS One

Implanted Carmustine Wafers Followed by Concomitant Radiochemotherapy to Treat Newly Diagnosed Malignant Gliomas: Prospective, Observational, Multicenter Study on 92 Cases

(2012) Julien Duntze et al.   ANNALS OF SURGICAL ONCOLOGY

O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w

(2012) Emmanuèle Lechapt-Zalcman et al.   CANCER

Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity

(2012) Petra Miglierini et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma

(2012) S. Ulmer et al.   NEURO-ONCOLOGY

Brain tumor and Gliadel wafer treatment

(2011) PM Parikh et al.   INDIAN JOURNAL OF CANCER

Retrospective Comparison of Chemoradiotherapy Followed by Adjuvant Chemotherapy, With or Without Prior Gliadel Implantation (Carmustine) After Initial Surgery in Patients With Newly Diagnosed High-Grade Gliomas

(2011) Georges Noël et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival

(2011) Kaisorn L Chaichana et al.   NEUROLOGICAL RESEARCH

Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience

(2010) Philippe Menei et al.   ANNALS OF SURGICAL ONCOLOGY

Incorporating BCNU Wafers into Malignant Glioma Treatment

(2010) Anne Balossier et al.   CLINICAL DRUG INVESTIGATION

A comprehensive outlook on intracerebral therapy of malignant gliomas

(2010) Carlo Buonerba et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

(2009) Mary Lou Affronti et al.   CANCER

Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors

(2009) Holly J. Meany et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

(2008) Frank J. Attenello et al.   ANNALS OF SURGICAL ONCOLOGY

Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme

(2008) Annunziato Mangiola et al.   CANCER

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY